New Zealand markets open in 9 hours 40 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
128.16-1.49 (-1.15%)
At close: 04:02PM EST
128.20 +0.04 (+0.03%)
After hours: 07:54PM EST
Full screen
Trade prices are not sourced from all markets
Previous close129.65
Bid128.15 x 1400
Ask128.20 x 800
Day's range127.02 - 130.59
52-week range105.36 - 142.60
Avg. volume5,527,730
Market cap226.624B
Beta (5Y monthly)0.70
PE ratio (TTM)31.80
Earnings dateN/A
Forward dividend & yield1.88 (1.47%)
Ex-dividend date13 Jan 2022
1y target estN/A
  • Motley Fool

    Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022?

    In particular, Abbott Laboratories (NYSE: ABT) makes BinaxNOW kits, which are the most popular rapid coronavirus antigen diagnostic test in the U.S. Are things different this time as a result of the omicron variant wave, or is Abbott on track to disappoint? Coronavirus rapid testing revenue has been all over the place, appearing to ebb and flow based on the public's perceptions about where the pandemic is headed.

  • Zacks

    Abbott (ABT) Gets FDA Nod for New Cardiac Mapping System

    Abbott's (ABT) EnSite X EP System with EnSite Omnipolar Technology offers a 360-degree view of the heart, regardless of catheter orientation, for cardiac mapping without compromise.

  • Motley Fool

    3 Reasons to Buy This Newly Minted Dividend King

    Last month, the diversified healthcare company Abbott Laboratories (NYSE: ABT) raised its quarterly dividend 4.4% from $0.45 to $0.47 per share. Abbott seems to be a thriving business based on its growing sales and profitability.